Inquis Medical is developing thrombectomy technology, enabling an efficient single-pass thrombectomy with minimal blood loss.
Inquis Medical has raised $75.0M in total funding. The most recent round was Series C. The last funding was announced in January 2026.
Inquis Medical's investors include Shangbay Capital, Yu Galaxy, Marshall Wace, Pierre Lamond, Synergy Partners International.
Inquis Medical is headquartered in Redwood City, United States.
Inquis Medical is developing thrombectomy technology, enabling an efficient single-pass thrombectomy with minimal blood loss.
Inquis Medical is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inquis Medical — Funding & Investors." VCBacked, January 12, 2026, https://www.vcbacked.co/company/inquis-medical. Accessed October 29, 2026.
VCBacked. (2026). Inquis Medical — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/inquis-medical
{{cite web |title=Inquis Medical — Funding & Investors |url=https://www.vcbacked.co/company/inquis-medical |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated